"Because we are in a health care setting, masks are still required in all facilities. Thank you for helping keep our patients and staff safe."

During the past decade, DRUG SHIPMENT: University of Colorado Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "DRUG SHIPMENT: University of Colorado Cancer Center" are "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "DRUG SHIPMENT: University of Colorado Cancer Center" in a lesser frequency.

Most popular intervention types in "DRUG SHIPMENT: University of Colorado Cancer Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "PF-02341066" (2 trials) and "PF-00299804" (1 trials). Other intervention names were less common.

The vast majority of trials in "DRUG SHIPMENT: University of Colorado Cancer Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "DRUG SHIPMENT: University of Colorado Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in DRUG SHIPMENT: University of Colorado Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in DRUG SHIPMENT: University of Colorado Cancer Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".